Delivery Order SPE2DB20D1100-SPE2DB24FA9D7
- Not listed
- The U.S. Defense Logistics Agency (DLA) awarded a firm fixed price delivery order contract worth $1,862.36 to AmerisourceBergen Drug Corp, a subsidiary of the global pharmaceutical distribution company AmerisourceBergen Corporation. The contract is for the delivery of Advair HFA 230-21 MCG inhalers to support military treatment programs and facilities. The delivery order was issued under an existing indefinite delivery contract (IDC) between DLA and AmerisourceBergen Drug Corp, which has a...
- The U.S. Defense Logistics Agency (DLA) awarded a firm fixed price delivery order contract worth $1,562.04 to Amerisourcebergen Drug Corp, a subsidiary of the global pharmaceutical company Amerisourcebergen Corporation, to provide Advair HFA 115-21 MCG inhalers. This award is part of a larger indefinite delivery contract (IDC) with a potential value of $999,999,999.00 that was previously awarded to Amerisourcebergen Drug Corp by DLA for the provision of a comprehensive range of pharmaceutical...
- The Defense Logistics Agency (DLA) awarded a firm fixed price delivery order contract to Amerisourcebergen Drug Corp, a subsidiary of the global pharmaceutical distribution company Amerisourcebergen Corporation. The contract, valued at $17,942.06, is for the supply of Advair HFA 230-21 MCG inhalers to support military medical treatment programs and facilities. This delivery order is part of a larger indefinite delivery contract (IDC) awarded to Amerisourcebergen Drug Corp, valued at up to...
- The Defense Logistics Agency (DLA) awarded Amerisourcebergen Drug Corp, a subsidiary of the global pharmaceutical distribution company Amerisourcebergen Corporation, a firm fixed price delivery order contract valued at $2,903.87 to provide an Advair HFA 115-21 mcg inhaler. This order falls under Amerisourcebergen Drug Corp's larger indefinite delivery contract (IDC) with DLA, valued at up to $999,999,999.00 through December 31, 2025. The IDC serves as the primary contract vehicle for...
- The U.S. Defense Logistics Agency (DLA) awarded a firm fixed price delivery order contract to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, for the supply of Advair HFA 115-21 MCG inhalers. The $12,577.37 contract has a period of performance through March 22, 2024. Amerisourcebergen Drug Corp is the prime contractor and no set-aside designation was used. This award is associated with a larger indefinite delivery contract (IDC) valued at up to $999,999,999.00 that...
- The U.S. Defense Logistics Agency (DLA) awarded a firm fixed price delivery order contract to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, for the supply of pharmaceutical products. Specifically, the contract is for the delivery of Advair HFA 230-21 MCG inhalers, with a ceiling value of $10,761.84 and a period of performance through April 4, 2024. This delivery order contract is part of a larger indefinite delivery contract (IDC) with a potential value of...
- The U.S. Defense Logistics Agency (DLA) has awarded a firm fixed price delivery order contract to AmerisourceBergen Drug Corp, a subsidiary of the global pharmaceutical distribution company AmerisourceBergen Corporation. The contract, valued at $10,223.64, is for the delivery of Advair HFA 115-21 MCG inhalers to support military treatment programs and facilities. This delivery order contract has an ultimate completion date of March 27, 2024. Additionally, AmerisourceBergen Drug Corp holds an...
- The U.S. Defense Logistics Agency (DLA) has awarded a firm fixed price delivery order valued at $5,393.88 to Amerisourcebergen Drug Corp, a leading global pharmaceutical distributor, for the provision of Advair HFA 115-21 mcg inhalers. This delivery order, with a period of performance through April 2, 2024, is issued under an indefinite delivery contract (IDC) with a potential value of up to $999,999,999.00 that enables Amerisourcebergen to deliver a comprehensive range of pharmaceutical...
- The Defense Logistics Agency (DLA) Troop Support Medical awarded a firm fixed price delivery order contract valued at $1,183.32 to Amerisourcebergen Drug Corp, a division of the global pharmaceutical company Amerisourcebergen Corporation. The contract is for the delivery of Advair HFA 230-21 mcg inhalers to support military treatment programs and facilities. This delivery order is part of a larger indefinite delivery contract (IDC) awarded solely to Amerisourcebergen Drug Corp, with a...
- The Defense Logistics Agency (DLA) awarded a firm fixed price delivery order contract worth $1,987.86 to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, for the supply of Advair HFA 230-21 MCG Inhaler, 12 gm. This delivery order contract has a completion date of January 26, 2024. Amerisourcebergen Drug Corp also holds an indefinite delivery contract (IDC) with DLA Troop Support Medical valued at up to $999,999,999.00, which serves as the primary contract vehicle for...
- SPE2DB20D1100Indefinite Delivery Contract
- SPE2DB20D1100-SPE2DB24FA9D7Delivery Order
The U.S. Defense Logistics Agency (DLA) awarded a firm fixed price delivery order contract to Amerisourcebergen Drug Corp, a subsidiary of the global pharmaceutical distributor Amerisourcebergen Corporation. The $19,197.68 contract is for the supply of Advair HFA 230-21 mcg inhalers to support U.S. military treatment programs and facilities. This award is under an indefinite delivery contract (IDC) held by Amerisourcebergen Drug Corp with DLA, which has a potential value of $999,999,999.00 and runs through December 31, 2025. The IDC does not have a set-aside designation and serves as the primary vehicle for Amerisourcebergen to provide pharmaceuticals and medical supplies to DLA Troop Support Medical. In addition to DLA, Amerisourcebergen Drug Corp holds a separate $750,000 indefinite delivery contract with the Department of Justice to provide medical supplies and prescription medications through May 2024.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $19.2k | 3/25/24 |